STOCK TITAN
  1. Home
  2. Sec-filings
  3. AMMJ
  4. [8-K] American Cannabis Company, Inc. Reports Material Event

Griffin Brahms joins American Cannabis Company (AMMJ) board

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

American Cannabis Company, Inc. filed a current report describing a change in its leadership. On May 6, 2026, the Board of Directors appointed Griffin Brahms as a member of the Board, effective immediately. This adds a director with focused experience in the regulated cannabis market.

Brahms has nearly a decade of industry experience in account management, business development, and client relations. Since 2018, he has served as an Account Manager at Harmony Extracts in Colorado, concentrating on retail partnerships, operational growth, and strategic business relationships, bringing practical market and customer insight to the boardroom.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Board appointment date May 6, 2026 Effective date of Griffin Brahms joining the Board of Directors
Report signature date May 11, 2026 Date CEO James Woodend signed the current report
Form 8-K regulatory
"2026-05-06 FORM 8-K : May 6, 2026 AMERICAN CANNABIS COMPANY, INC."
A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.
Board of Directors financial
"the Board of Directors of AMMJ (the “Company”) appointed Griffin Brahms"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Emerging growth company regulatory
"Emerging growth company [ ]"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
account management financial
"nearly a decade of experience in account management, business development, and client relations"
Understanding 8-K Material Events →
false 0000945617 0000945617 2026-05-06 2026-05-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 6, 2026

 

 

AMERICAN CANNABIS COMPANY, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

(State or other jurisdiction of incorporation or organization)

Commission File Number

000-26108

90-1116625

(I.R.S. Employer

Identification Number)

 

1004 S Tejon St Colorado Springs, CO 80903

(Address of Principal Executive Offices and Zip Code) 

(303) 974-4770

(Issuer's telephone number)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class Trading Symbols Name of Exchange on Which Registered
Common AMMJ None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [ ]

 

 

Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.

On May 6, the Board of Directors of AMMJ (the “Company”) appointed Griffin Brahms to serve as a member of the Company’s Board of Directors, effective immediately.

Mr. Brahms is a cannabis industry professional with nearly a decade of experience in account management, business development, and client relations within the regulated cannabis market. Since 2018, he has served as an Account Manager at Harmony Extracts in Colorado, where he has focused on retail partnerships, operational growth, and strategic business relationships.

Prior to his work in the cannabis industry, Mr. Brahms worked in digital content and market research in New York City, developing experience in consumer behavior, brand strategy, and audience engagement.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

AMERICAN CANNABIS COMPANY, INC.

(Registrant)

 

 

By: /s/ James Woodend

Name: James Woodend

Date: May 11, 2026

Title: CEO

 

 

 

 

Source: View Original Filing on SEC EDGAR

FAQ

What did American Cannabis Company (AMMJ) report in its latest Form 8-K?

American Cannabis Company reported the appointment of Griffin Brahms to its Board of Directors. The filing focuses on this leadership change and outlines his background in the regulated cannabis industry and related business development roles.

Who is Griffin Brahms, the new director at American Cannabis Company (AMMJ)?

Griffin Brahms is a cannabis industry professional with nearly a decade of experience. He has worked in account management, business development, and client relations, primarily within regulated cannabis markets and previously in digital content and market research.

When did Griffin Brahms join the Board of American Cannabis Company (AMMJ)?

Griffin Brahms was appointed to the Board of Directors on May 6, 2026. The appointment was effective immediately, meaning he began serving as a director from that date according to the company’s Form 8-K disclosure.

What relevant experience does Griffin Brahms bring to American Cannabis Company (AMMJ)?

Brahms brings experience in account management, business development, and client relations in regulated cannabis. At Harmony Extracts, he focuses on retail partnerships, operational growth, and strategic business relationships, complementing earlier work in consumer behavior and brand strategy.

What role does Harmony Extracts play in Griffin Brahms’s background relevant to AMMJ?

Since 2018, Brahms has served as an Account Manager at Harmony Extracts in Colorado. There he has focused on retail partnerships, operational growth, and strategic business relationships, providing direct, practical experience in the cannabis products market.

Filing Exhibits & Attachments

3 documents

Other Documents